November 18, 2015 – On November 9, 2015 Magistrate Judge Christopher J. Burke of the District Court for the District of Delaware recommended granting Plaintiff, W.L. Gore and Associates Inc.’s motion for summary judgment that its stent graft patent was not invalid as anticipated by a prior art patent and rejected Defendant, C.R. Bard Inc.’s inherent anticipation argument. The patent-at-issue in this case is U.S. Patent No. 5,735,892, titled “Intraluminal Stent Graft,” which covers an expandable metal stent for recurrent tracheal obstruction.
By: Giancarlo L. Scaccia